385 studies found for:    Open Studies | "Nevus"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Nevus"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)
Condition: Dysplastic Nevus Syndrome
Intervention: Drug: 20% betulinic acid ointment
2 Unknown  Genetic Identification (ID) of Segmental Dysplastic Nevi
Condition: Segmental Dysplastic Nevi
Intervention: Procedure: Punch Biopsy
3 Not yet recruiting Classification and Longitudinal Follow-up of Common Melanocytic Nevi With in Vivo Reflectance Confocal Microscopy
Condition: Common Melanocytic Nevi
Intervention: Device: RCM imaging
4 Recruiting Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions
Conditions: Atypical Nevi;   Melanoma
Intervention: Drug: broccoli sprout extract - sulforaphane (BSE-SFN)
5 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
6 Recruiting Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles
Condition: Hydatidiform Moles
Intervention:
7 Unknown  Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
Conditions: Malignant Melanoma;   Pigmented Nevi;   Skin Neoplasm
Intervention:
8 Recruiting A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole
Condition: Hydatidiform Mole
Intervention: Procedure: Suction and evacuation
9 Unknown  Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Condition: Melanoma
Intervention:
10 Recruiting Trial Comparing the Effects of Intermittent Vismodegib Versus Photodynamic Therapy in Patients With Multiple Basal Cell Carcinomas
Conditions: Basal Cell Nevus Syndrome;   Gorlin's Syndrome
Interventions: Drug: GDC-0449;   Procedure: Aminolevulinic acid %20 topical solution + blue light
11 Recruiting Clinical and Histopathologic Characteristics of BAP1 Mutations
Conditions: Malignant Pleural Mesothelioma (MPM);   Choroidal Nevus;   Primary Uveal Melanoma (UM);   Metastatic Uveal Melanoma (UM)
Intervention: Other: tumor specimens
12 Recruiting Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Condition: Patients at Risk for Melanoma
Interventions: Drug: N-acetylcysteine;   Other: Placebo arm
13 Recruiting An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
Condition: Basal Cell Carcinoma
Intervention:
14 Unknown  Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
15 Recruiting Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome
Conditions: Basal Cell Carcinoma;   Gorlin Syndrome;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: LDE225;   Drug: Placebo
16 Recruiting Family Study of Melanoma in Italy
Condition: Melanoma
Intervention:
17 Unknown  Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
Conditions: Melanoma;   Radiotherapy;   Metastatic Disease
Intervention: Procedure: Treatment of metastatic disease
18 Unknown  Treatment Of Radiation Retinopathy Trial
Condition: Uveal Melanoma
Interventions: Drug: ranibizumab;   Drug: triamcinolone acetonide;   Other: sham
19 Recruiting A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumbab Therapy in Patients With Advanced Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: Bacillus Calmette-Guérin (BCG) vaccine;   Drug: Ipilimumab
20 Recruiting Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Condition: Melanoma
Intervention: Biological: NY-ESO-1

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years